{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:45:58Z","timestamp":1778917558029,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1245\/s10434-024-14901-0","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T14:15:58Z","timestamp":1706192158000},"page":"2391-2400","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Normal CEA Levels After Neoadjuvant Chemotherapy and Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion Predict Improved Survival from Colorectal Peritoneal Metastases"],"prefix":"10.1245","volume":"31","author":[{"given":"Michael M.","family":"Wach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey","family":"Nunns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Hamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Derby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Jelinek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curtis","family":"Tatsuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew P.","family":"Holtzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amer H.","family":"Zureikat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven A.","family":"Ahrendt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James F.","family":"Pingpank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Haroon A.","family":"Choudry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Ongchin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,25]]},"reference":[{"issue":"27","key":"14901_CR1","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.3748\/wjg.v25.i27.3484","volume":"25","author":"JM Sanchez-Hidalgo","year":"2019","unstructured":"Sanchez-Hidalgo JM, Rodriguez-Ortiz L, Arjona-Sanchez A, et al. Colorectal peritoneal metastases: optimal management review. World J Gastroenterol. 2019;25(27):3484\u2013502.","journal-title":"World J Gastroenterol."},{"issue":"12","key":"14901_CR2","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1046\/j.1365-2168.2002.02274.x","volume":"89","author":"DG Jayne","year":"2002","unstructured":"Jayne DG, Fook S, Loi C, Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2002;89(12):1545\u201350.","journal-title":"Br J Surg."},{"issue":"2","key":"14901_CR3","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/jso.26322","volume":"123","author":"VH Le","year":"2021","unstructured":"Le VH, Thornblade L, Ituarte PHG, Lai LL, Melstrom KA. Metachronous peritoneal metastases following curative resection for colon cancer: Understanding risk factors and patterns of recurrence. J Surg Oncol. 2021;123(2):622\u20139.","journal-title":"J Surg Oncol."},{"issue":"2","key":"14901_CR4","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","volume":"88","author":"B Sadeghi","year":"2000","unstructured":"Sadeghi B, Arvieux C, Glehen O, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. 2000;88(2):358\u201363.","journal-title":"Cancer."},{"issue":"4","key":"14901_CR5","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1245\/ASO.2004.08.014","volume":"11","author":"VJ Verwaal","year":"2004","unstructured":"Verwaal VJ, Boot H, Aleman BM, van Tinteren H, Zoetmulder FA. Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: location, treatment, and outcome. Ann Surg Oncol. 2004;11(4):375\u20139. https:\/\/doi.org\/10.1245\/ASO.2004.08.014.","journal-title":"Ann Surg Oncol."},{"issue":"9","key":"14901_CR6","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","volume":"15","author":"VJ Verwaal","year":"2008","unstructured":"Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2008;15(9):2426\u201332. https:\/\/doi.org\/10.1245\/s10434-008-9966-2.","journal-title":"Ann Surg Oncol."},{"key":"14901_CR7","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1097\/SLA.0b013e31827e9289","volume":"257","author":"D Go\u00e9r\u00e9","year":"2013","unstructured":"Go\u00e9r\u00e9 D, Malka D, Tzanis D, et al. Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy? Ann Surg. 2013;257:1065\u201371.","journal-title":"Ann Surg"},{"issue":"9","key":"14901_CR8","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1245\/s10434-015-4387-5","volume":"22","author":"D Goere","year":"2015","unstructured":"Goere D, Souadka A, Faron M, et al. Extent of colorectal peritoneal carcinomatosis: attempt to define a threshold above which HIPEC does not offer survival benefit: a comparative study. Ann Surg Oncol. 2015;22(9):2958\u201364. https:\/\/doi.org\/10.1245\/s10434-015-4387-5.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"14901_CR9","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.21037\/jgo.2019.01.36","volume":"10","author":"SY Yang","year":"2019","unstructured":"Yang SY, Kang JH, Kim HS, Han YD, Min BS, Lee KY. Status of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer. J Gastrointest Oncol. 2019;10(6):1251\u201365.","journal-title":"J Gastrointest Oncol."},{"issue":"2","key":"14901_CR10","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","volume":"22","author":"F Qu\u00e9net","year":"2021","unstructured":"Qu\u00e9net F, Elias D, Roca L, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(2):256\u201366.","journal-title":"Lancet Oncol."},{"key":"14901_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2147\/CMAR.S119569","volume":"9","author":"GA Simkens","year":"2017","unstructured":"Simkens GA, Rovers KP, Nienhuijs SW, de Hingh IH. Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer. Cancer Manag Res. 2017;9:259\u201366.","journal-title":"Cancer Manag Res."},{"issue":"2","key":"14901_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/jso.20049","volume":"86","author":"E de Bree","year":"2004","unstructured":"de Bree E, Koops W, Kroger R, van Ruth S, Witkamp AJ, Zoetmulder FA. Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement. J Surg Oncol. 2004;86(2):64\u201373.","journal-title":"J Surg Oncol."},{"issue":"6","key":"14901_CR13","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3393\/ac.2019.11.13","volume":"35","author":"C Hall","year":"2019","unstructured":"Hall C, Clarke L, Pal A, et al. A review of the role of carcinoembryonic antigen in clinical practice. Ann Coloproctol. 2019;35(6):294\u2013305.","journal-title":"Ann Coloproctol."},{"issue":"3","key":"14901_CR14","first-page":"1041","volume":"36","author":"YR Huo","year":"2016","unstructured":"Huo YR, Huang Y, Liauw W, Zhao J, Morris DL. Prognostic value of carcinoembryonic antigen (CEA), AFP, CA19-9 and CA125 for patients with colorectal cancer with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Anticancer Res. 2016;36(3):1041\u20139.","journal-title":"Anticancer Res."},{"issue":"3","key":"14901_CR15","doi-asserted-by":"publisher","first-page":"O91","DOI":"10.1111\/codi.13273","volume":"18","author":"CJ Verberne","year":"2016","unstructured":"Verberne CJ, Wiggers T, Grossmann I, de Bock GH, Vermeulen KM. Cost-effectiveness of a carcinoembryonic antigen (CEA) based follow-up programme for colorectal cancer (the CEA Watch trial). Colorectal Dis. 2016;18(3):O91\u20136.","journal-title":"Colorectal Dis."},{"issue":"4","key":"14901_CR16","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1245\/s10434-014-4158-8","volume":"22","author":"S Stremitzer","year":"2015","unstructured":"Stremitzer S, Stift J, Graf A, et al. CEA change after neoadjuvant chemotherapy including bevacizumab and clinical outcome in patients undergoing liver resection for colorectal liver metastases. Ann Surg Oncol. 2015;22(4):1315\u201323. https:\/\/doi.org\/10.1245\/s10434-014-4158-8.","journal-title":"Ann Surg Oncol."},{"key":"14901_CR17","unstructured":"American Joint Committee on Cancer. Chapter 20\u2014Colon and rectum. In: AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017."},{"key":"14901_CR18","unstructured":"NCCN Clinical Practice Guidelines in Oncology for Colon Cancer V1.2023. National Comprehensive Cancer Network, 2023. Accessed [June 15,2023]."},{"issue":"6","key":"14901_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0233687","volume":"15","author":"CS Huang","year":"2020","unstructured":"Huang CS, Chen CY, Huang LK, Wang WS, Yang SH. Prognostic value of postoperative serum carcinoembryonic antigen levels in colorectal cancer patients who smoke. PLoS ONE. 2020;15(6):e0233687.","journal-title":"PLoS ONE."},{"issue":"1","key":"14901_CR20","doi-asserted-by":"publisher","first-page":"19044","DOI":"10.1038\/s41598-021-98513-8","volume":"11","author":"Y Yang","year":"2021","unstructured":"Yang Y, Xu M, Huang H, et al. Serum carcinoembryonic antigen elevation in benign lung diseases. Sci Rep. 2021;11(1):19044.","journal-title":"Sci Rep."},{"issue":"4","key":"14901_CR21","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/jso.24911","volume":"117","author":"MA Kozman","year":"2018","unstructured":"Kozman MA, Fisher OM, Rebolledo BJ, et al. CEA to peritoneal carcinomatosis index (PCI) ratio is prognostic in patients with colorectal cancer peritoneal carcinomatosis undergoing cytoreduction surgery and intraperitoneal chemotherapy: a retrospective cohort study. J Surg Oncol. 2018;117(4):725\u201336.","journal-title":"J Surg Oncol."},{"issue":"4B","key":"14901_CR22","first-page":"3031","volume":"21","author":"T Nakagoe","year":"2001","unstructured":"Nakagoe T, Sawai T, Ayabe H, et al. Prognostic value of carcinoembryonic antigen (CEA) in tumor tissue of patients with colorectal cancer. Anticancer Res. 2001;21(4B):3031\u20136.","journal-title":"Anticancer Res."},{"key":"14901_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.yexcr.2014.04.007","volume":"324","author":"O Bajenova","year":"2014","unstructured":"Bajenova O, Chaika N, Tolkunova E, et al. Carcinoembryonic antigen promotes colorectal cancer progression by targeting adherens junction complexes. Exp Cell Res. 2014;324:115\u201323.","journal-title":"Exp Cell Res."},{"issue":"5","key":"14901_CR24","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.hpb.2023.01.016","volume":"25","author":"H Liu","year":"2023","unstructured":"Liu H, D\u2019Alesio M, AlMasri S, et al. No survival benefit with suboptimal CA19-9 response: defining effective neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer. HPB (Oxford). 2023;25(5):521\u201332.","journal-title":"HPB (Oxford)."},{"key":"14901_CR25","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ejca.2020.11.025","volume":"144","author":"RP Jones","year":"2021","unstructured":"Jones RP, Pugh SA, Graham J, Primrose JN, Barriuso J. Circulating tumour DNA as a biomarker in resectable and irresectable stage IV colorectal cancer; a systematic review and meta-analysis. Eur J Cancer. 2021;144:368\u201381.","journal-title":"Eur J Cancer."},{"issue":"6","key":"14901_CR26","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.3390\/jcm9061738","volume":"9","author":"JJ Beagan","year":"2020","unstructured":"Beagan JJ, Sluiter NR, Bach S, et al. Circulating tumor DNA as a preoperative marker of recurrence in patients with peritoneal metastases of colorectal cancer: a clinical feasibility study. J Clin Med. 2020;9(6):1738.","journal-title":"J Clin Med."},{"key":"14901_CR27","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1245\/s10434-022-12399-y","volume":"30","author":"BG Sullivan","year":"2023","unstructured":"Sullivan BG, Lo A, Yu J, et al. Circulating tumor DNA is unreliable to detect somatic gene alterations in gastrointestinal peritoneal carcinomatosis. Ann Surg Oncol. 2023;30:278\u201384. https:\/\/doi.org\/10.1245\/s10434-022-12399-y.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"14901_CR28","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.1245\/s10434-023-13219-7","volume":"30","author":"PA Vallejos","year":"2023","unstructured":"Vallejos PA, Gonda A, Yu J, et al. Plasma exosome gene signature differentiates colon cancer from healthy controls. Ann Surg Oncol. 2023;30(6):3833\u201344. https:\/\/doi.org\/10.1245\/s10434-023-13219-7.","journal-title":"Ann Surg Oncol."},{"key":"14901_CR29","doi-asserted-by":"publisher","unstructured":"Dhiman A, Kothary V, Witmer HDD, et al. Role of tumor-informed personalized ctdna assay in informing recurrence in patients with peritoneal metastases from colorectal and high-grade appendix cancer undergoing curative intent surgery. Ann Surg. 2023. doi: https:\/\/doi.org\/10.1097\/SLA.0000000000005856. Epub ahead of print.","DOI":"10.1097\/SLA.0000000000005856"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-14901-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-14901-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-14901-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T14:03:34Z","timestamp":1709733814000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-14901-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,25]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["14901"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-14901-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,25]]},"assertion":[{"value":"16 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}